Our first story highlights Odin Medical’s FDA clearance for a cloud-based AI tool for detecting colorectal polyps during colonoscopies. The second story addresses updated estimates of atrial fibrillation (AF) prevalence in the U.S., revealing a significant increase in diagnosed cases, especially among younger, hypertensive, and diabetic patients. Finally, we explore new data on the the efficacy of Trastuzumab deruxtecan (T-DXd) in treating HER2+ metastatic breast cancer.

Learn about the mpox outbreak in Africa, how upper gastrointestinal mucosal damage may increase the risk of Parkinson's disease, and the public health consequences of increased pesticide use.

Learn about a study in NEJM which found no significant benefits from discontinuing beta-blocker therapy in MI patients, gut microbiota's potential influence on hematologic cancers and, data from ESC Congress 2024 suggesting that catching up on sleep during weekends may reduce heart disease risk by up to 20%.

Does long COVID present differently in children and adolescents? Find out about this and more in today's PeerDirect Medical News Podcast.

Dr. Wohl rejoins the podcast to discuss the newly released data about the twice-yearly injections of lenacapavir for PrEP in uninfected cis-gender women, the search for a HIV vaccine, disparities in diagnosis and treatment of HIV and the latest round of COVID vaccines.

Can artificial intelligence restore speech in patients with ALS? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. Lake D. Morrison and Joseph G. Mammarappallil conclude their discussion of ILAs as key precursors to ILDs, reviewing a patient case and addressing considerations when ordering imaging studies, focusing on HRCT scans, their optimal cut widths, views, and more, to help identify and differentiate ILAs from other lung abnormalities.

Drs. Lake D. Morrison and Joseph G. Mammarappallil discuss ILAs as key precursors to ILDs, including defining what ILAs are, their identification by imaging specialists, as well as the clinical implications of ILAs for HCPs caring for these patients.

Drs. Tanzira Zaman and Elizabeth Volkmann conclude their discussion of ILDs for the non‑pulmonologist, delving into the management of ILDs and how that can significantly improve patient outcomes, especially for those with autoimmune disease.

Drs. Tanzira Zaman and Elizabeth Volkmann discuss ILDs for the non‑pulmonologist and cover the overlap between pulmonology and rheumatology and why it is crucial for non‑pulmonologists to understand ILDs. They also discuss why early recognition and management of ILDs can significantly improve patient outcomes, especially for those with autoimmune disease.